“…Apoptosis, a phenomenon controlled by a tight equilibrium between inducer and suppressor genes (Evan et al, 1992;Farrow et al, 1995;Oltvai et al, 1993;Yang et al, 1995;Yonish-Rouach et al, 1991), can be inhibited by transfection of antiapoptotic genes such as bcl-2-related genes (Boise et al, 1993;Reed, 1994) or the adenovirus E1B-19K gene (Teodoro and Branton, 1997). Indeed, constitutive overexpression of Bcl-2, Bcl-X L , or E1B-19K in B-cell hybridomas has been shown to prolong viability of cultured hybridomas (Charbonneau and Gauthier, 2000;Fassnacht et al, 1998;Gauthier et al, 1996;Ishaque and Al-Rubeai, 1998;Mercille et al, 1999;Minn et al, 1995;Murray et al, 1996;Singh et al, 1996;Terada et al, 1997). However, constitutive overexpression of bcl-2-related genes has been shown to have detrimental eects on genomic stability of other cell types by preventing p53-induced apoptotic death of cells bearing genetic abnormalities such as mutations or mitotic damage (Cherbonnel-Lasserre et al, 1996;Minn et al, 1996).…”